ATE479743T1 - Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays - Google Patents

Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays

Info

Publication number
ATE479743T1
ATE479743T1 AT03784853T AT03784853T ATE479743T1 AT E479743 T1 ATE479743 T1 AT E479743T1 AT 03784853 T AT03784853 T AT 03784853T AT 03784853 T AT03784853 T AT 03784853T AT E479743 T1 ATE479743 T1 AT E479743T1
Authority
AT
Austria
Prior art keywords
chemotherapeutic
assay
cell cultures
producing cell
biological preparations
Prior art date
Application number
AT03784853T
Other languages
English (en)
Inventor
Paul Kornblith
Sheri Gimigliano
Original Assignee
Precision Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Precision Therapeutics Inc filed Critical Precision Therapeutics Inc
Application granted granted Critical
Publication of ATE479743T1 publication Critical patent/ATE479743T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C12N2503/02—Drug screening
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03784853T 2002-07-30 2003-07-30 Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays ATE479743T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/208,480 US20040023375A1 (en) 2002-07-30 2002-07-30 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
PCT/US2003/023888 WO2004015065A2 (en) 2002-07-30 2003-07-30 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays

Publications (1)

Publication Number Publication Date
ATE479743T1 true ATE479743T1 (de) 2010-09-15

Family

ID=31186831

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784853T ATE479743T1 (de) 2002-07-30 2003-07-30 Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays

Country Status (6)

Country Link
US (2) US20040023375A1 (de)
EP (1) EP1572969B1 (de)
AT (1) ATE479743T1 (de)
AU (1) AU2003261308A1 (de)
DE (1) DE60334025D1 (de)
WO (1) WO2004015065A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023375A1 (en) * 2002-07-30 2004-02-05 Precision Therapeutics, Inc. Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US5728541A (en) * 1996-07-12 1998-03-17 Precision Therapeutics, Inc. Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
US7276351B2 (en) * 2003-09-10 2007-10-02 Seahorse Bioscience Method and device for measuring multiple physiological properties of cells
US20070087401A1 (en) * 2003-10-17 2007-04-19 Andy Neilson Analysis of metabolic activity in cells using extracellular flux rate measurements
US8658349B2 (en) 2006-07-13 2014-02-25 Seahorse Bioscience Cell analysis apparatus and method
DE102005015953A1 (de) * 2005-04-07 2006-10-12 Medizinische Hochschule Hannover Verfahren zur Anreicherung und ex vivo Kultivierung von Brustprimärzellen
WO2007028146A2 (en) * 2005-09-01 2007-03-08 Precision Therapeutics, Inc. Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics
WO2008118846A1 (en) 2007-03-23 2008-10-02 Precision Therapeutics, Inc. Methods for evaluating angiogenic potential in culture
EP2207892A4 (de) 2007-10-15 2010-12-08 Precision Therapeutics Inc Verfahren zur selektion aktiver agentien für die krebsbehandlung
CN102016581B (zh) 2008-02-25 2014-07-30 雀巢产品技术援助有限公司 用抗体阵列选择乳腺癌治疗药物
US20100311084A1 (en) * 2008-05-14 2010-12-09 Precision Therapeutics, Inc. Methods for predicting a patient's response to egfr inhibitors
US8202702B2 (en) * 2008-10-14 2012-06-19 Seahorse Bioscience Method and device for measuring extracellular acidification and oxygen consumption rate with higher precision
US20110238322A1 (en) * 2008-11-03 2011-09-29 Precision Therapeutics, Inc. Methods of simulating chemotherapy for a patient
US20110014644A1 (en) 2009-06-22 2011-01-20 Precision Therapeutics, Inc. Methods for predicting a cancer patient's response to antifolate chemotherapy
JP5795311B2 (ja) 2009-07-15 2015-10-14 ネステク ソシエテ アノニム 抗体ベースのアレイを使用する胃癌療法のための薬物選択
CN102947710B (zh) 2010-01-28 2015-01-14 3D生物母体公司 悬滴装置、***和/或方法
EP2920292B1 (de) 2012-11-13 2017-01-11 Agilent Technologies, Inc. Vorrichtung und verfahren für dreidimensionale gewebemessungen auf basis eines kontrollierten medienstroms
JP6739351B2 (ja) 2014-06-02 2020-08-12 シーホース バイオサイエンス インコーポレイテッド 生物試料分析用の単一列マイクロプレートシステム及び搬送体

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US192638A (en) * 1877-07-03 Improvement in umbrella tip-cups
US168679A (en) * 1875-10-11 Improvement in variable measures
US4423145A (en) * 1981-05-07 1983-12-27 Stampfer Martha R Enhanced growth medium and method for culturing human mammary epithelial cells
US4668618A (en) * 1981-09-14 1987-05-26 Thornthwaite Jerry T Nuclear isolation medium and procedure for separating cell nuclei
US4937187A (en) * 1983-02-04 1990-06-26 Brown University Research Foundation Methods for separating malignant cells from clinical specimens
US4559299A (en) * 1983-02-04 1985-12-17 Brown University Research Foundation Inc. Cytotoxicity assays in cell culturing devices
US4816395A (en) * 1985-12-19 1989-03-28 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US4937182A (en) * 1985-12-19 1990-06-26 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US5266480A (en) * 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US4996145A (en) * 1987-10-27 1991-02-26 Oncotech Incorporated Method for detecting immune-mediated cytotoxicity
US5242806A (en) * 1990-05-07 1993-09-07 Baxter Diagnostics Inc. Method for conducting the cytotoxicity assays on tumor cells
US5874218A (en) * 1990-06-11 1999-02-23 Nexstar Pharmaceuticals, Inc. Method for detecting a target compound in a substance using a nucleic acid ligand
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US5270172A (en) * 1991-04-26 1993-12-14 Dekk-Tek, Inc. Method to predict tumor response to therapy
US5407653A (en) * 1991-06-26 1995-04-18 Brigham And Women's Hospital Evaluation of the multidrug resistance phenotype
US5837747A (en) * 1991-10-29 1998-11-17 Vivorx, Inc. Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release
WO1994000470A1 (en) * 1992-06-30 1994-01-06 The Wistar Institute Of Anatomy And Biology DEVELOPMENTAL EMBRYONIC MOUSE cDNA LIBRARIES
US5585265A (en) * 1992-11-30 1996-12-17 Gillette Company Human corneal epithelial cell lines with extended lifespan
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5888765A (en) * 1995-06-23 1999-03-30 President And Fellows Of Harvard College Endothelial-cell specific promoter
US6274576B1 (en) * 1995-06-27 2001-08-14 The Henry Jackson Foundation For The Advancement Of Military Medicine Method of dynamic retardation of cell cycle kinetics to potentiate cell damage
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US6416967B2 (en) * 1996-07-12 2002-07-09 Precision Therapeutics, Inc. Method of using multicellular particulates to analyze malignant or hyperproliferative tissue
US20020168679A1 (en) 1998-06-11 2002-11-14 Gregory J. Naus Staining agents and protocols for characterizing malignant cells in culture
US5728541A (en) * 1996-07-12 1998-03-17 Precision Therapeutics, Inc. Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
US20040023375A1 (en) 2002-07-30 2004-02-05 Precision Therapeutics, Inc. Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
US20040072722A1 (en) 2002-10-10 2004-04-15 Kornblith Paul L. Methods for assessing efficacy of chemotherapeutic agents
US6008007A (en) * 1997-01-31 1999-12-28 Oncotech, Inc. Radiation resistance assay for predicting treatment response and clinical outcome
US5840507A (en) * 1997-03-19 1998-11-24 Oncotech, Inc. Methods for cancer prognosis and diagnosis
US5972639A (en) * 1997-07-24 1999-10-26 Irori Fluorescence-based assays for measuring cell proliferation
US6074874A (en) * 1997-08-29 2000-06-13 University Of Pittsburgh Epithelial cell cultures for in vitro testing
US6111092A (en) * 1998-06-03 2000-08-29 Millennium Pharmaceuticals, Inc. Nucleic acid molecules encoding DRT111 and uses thereof
US6537759B1 (en) * 1998-07-20 2003-03-25 Variagenics, Inc. Folylpolyglutamate synthetase gene sequence variances having utility in determining the treatment of disease
CN1334875A (zh) 1998-10-13 2002-02-06 昂尼克斯药物公司 新颖的细胞信号多肽和核酸
WO2000052204A2 (en) * 1999-02-22 2000-09-08 Orntoft Torben F Gene expression in bladder tumors
EP1059352A1 (de) * 1999-06-08 2000-12-13 Oncodia AG Langzeitkultur humaner Karzinome
CA2390305A1 (en) * 1999-11-03 2001-05-10 Oncotech, Inc. Methods for cancer prognosis and diagnosis
WO2001035316A2 (en) 1999-11-10 2001-05-17 Structural Bioinformatics, Inc. Computationally derived protein structures in pharmacogenomics
AU2001240998A1 (en) 2000-03-06 2001-09-17 Technion Research And Development Foundation Ltd. Method of and kit for assessing responsiveness of cancer patients to antifolate chemotherapy
JP5156163B2 (ja) 2000-04-18 2013-03-06 ビルコ・ビーブイビーエイ 薬剤耐性の測定方法
AU2002224435A1 (en) 2000-10-18 2002-04-29 Precision Therapeutics, Inc. Method for tandem genomic/proteomic analyses of proliferating cells
WO2002057499A2 (en) 2001-01-12 2002-07-25 Washington State University Research Foundation Mdr1 variants and methods for their use
US20040086888A1 (en) * 2001-10-18 2004-05-06 Kornblith Paul L Method for tandem genomic/proteomic analysis of proliferating cells
US7767390B2 (en) 2001-11-20 2010-08-03 Oncomedx, Inc. Methods for evaluating drug-resistance gene expression in the cancer patient

Also Published As

Publication number Publication date
US20070059821A1 (en) 2007-03-15
EP1572969A2 (de) 2005-09-14
EP1572969B1 (de) 2010-09-01
EP1572969A4 (de) 2007-06-06
US7972769B2 (en) 2011-07-05
DE60334025D1 (de) 2010-10-14
WO2004015065A3 (en) 2006-10-05
US20040023375A1 (en) 2004-02-05
AU2003261308A8 (en) 2004-02-25
AU2003261308A1 (en) 2004-02-25
WO2004015065A2 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
ATE479743T1 (de) Verfahren zur herstellung von zellkulturen aus biologischen präparaten für chemotherapeutische und andere assays
ATE365793T1 (de) Verfahren zur isolierung und kulturexpansion mesenchymaler stamm-/vorläuferzellen aus nabelschnurblut sowie verfahren zur differenzierung von aus nabelschnurblut stammenden mesenchymalen stamm-/vorläuferzellen in unterschiedliche mesenchymgewebe
WO2001081549A3 (en) Hepatocyte lineage cells derived from pluripotent stem cells
DE602004025805D1 (de) Verfahren zur herstellung von antikörpern
DE602004014158D1 (de) Verfahren zur herstellung von l-lysin oder l-threonin unter verwendung von escherichia-bakterien mit abgeschwächter malatenzymaktivität
ATE408004T1 (de) Vögelzell-linien und deren verwendung zur herstellung interessanter biologischer substanzen
ATE496627T1 (de) Mischzell-populationen für die gewebereparatur und trenntechnik für die zellaufbereitung
HK1093755A1 (en) Method for differentiating mesenchymal stem cell into neural cell
TW200636068A (en) A method of culturing a cell and use of the same
SG158025A1 (en) Growth medium c. histolyticum without ingredients of mamalian sources
ATE430807T1 (de) Verfahren zur kultivierung von circovirus
ATE517176T1 (de) Verfahren zur kultivierung von geschmackszellen aus säugern
WO2004090096A3 (en) Methods for neural differentiation of embryonic stem cells using protease passaging techniques
DE69935978D1 (de) Kulturmedium zur kultivierung tierischer zellen und verfahren zur herstellung von proteinen durch dessen verwendung
WO2003010304A3 (de) Verfahren zur herstellung isolierter zellkulturen, kulturmedium zur kultivierung von zellkulturen und zellkultur
ATE336567T1 (de) Zellkulturmedium
ATE530657T1 (de) Verfahren zur herstellung von zellinien mit latentem immunschwächevirus
ATE521697T1 (de) Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
NO20006051L (no) Fremgangsmåte for fremstilling av dyrkning av celleaggregater referert til som primmorfer fra dissosierte celler fra svamper, koraller og andre invertebrater, samt anvendelse av disse
DE602006014534D1 (de) Herstellung und verwendung von basalmembranpartikeln
ATE201908T1 (de) Verfahren zur herstellung von riboflavin mittels mikroorganismen mit veränderter isocitratlyase- aktivität
FR2848565B1 (fr) Lignee de cellules dendritiques gen2.2
ATE449162T1 (de) Herstellung von tcr gamma delta t-zellen
WO2004078915A3 (en) Cell culture
EP1477555A3 (de) Verfahren zur Kultivierung von Bakterienzellen der Gattung Enterococcus und Verfahren zur Herstellung der abgetöteten Bakterienzellen der Gattung Enterococcus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties